🔎 Trials Near Me

Home › Breast Cancer › Massachusetts › Worcester

Breast Cancer clinical trials in Worcester, MA

6 studies for Breast Cancer are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

RecruitingPhase 3
  • Dana-Farber Brigham Cancer Center at Milford Regional Medical Center, Milford · 17 mi away
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06377852

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RecruitingPhase 3
  • University of Massachusetts Medical School, Worcester
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

RecruitingPhase 3
  • Dana-Farber Cancer Institute at Milford Regional, Milford · 17 mi away
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06492616

ATEMPT 2.0: Adjuvant T-DM1 vs TH

RecruitingPhase 2
  • Dana-Farber at Milford, Milford · 17 mi away
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04893109

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

RecruitingPhase 2
  • DFCI @ Milford Regional Hospital, Milford · 17 mi away
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT04468061

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Worcester
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Breast Cancer

Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.

More about Breast Cancer on MedlinePlus

Breast Cancer trials in other cities

Other studies in Worcester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.